| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002048170A1 Lipids comprising an aminoxy group |
| 06/20/2002 | WO2002047731A2 Drug delivery compositions and coated medical devices |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047717A2 Targeted enzyme prodrug therapy |
| 06/20/2002 | WO2002031110A3 Hematopoietic stem cell gene therapy |
| 06/20/2002 | WO2002030320A3 Stimulation of thymus for vaccination development |
| 06/20/2002 | WO2002028406A3 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 06/20/2002 | WO2002008751A8 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 06/20/2002 | WO2002004608A3 Regulation of human oligopeptidase a-like enzyme |
| 06/20/2002 | WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use |
| 06/20/2002 | WO2002000232A3 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 06/20/2002 | WO2001094613A3 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 06/20/2002 | WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/20/2002 | WO2001090139A3 A ligand for enhancing oral and cns delivery of biological agents |
| 06/20/2002 | WO2001085959A3 Regulation of human lysostaphin-like protease |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 06/20/2002 | WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same |
| 06/20/2002 | WO2001074897A3 Protein amf-1 to amf-10 and nucleic acids encoding the same |
| 06/20/2002 | WO2001068851A3 Polypeptides and nucleic acids encoding same |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2001048236A9 METHODS FOR IDENTIFYING AGENTS CAPABLE OF MODULATING PROTEIN KINASE C THETA (PKCυ) ACTIVITY |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001040461A3 Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and c |
| 06/20/2002 | WO2001027154A3 Membrane translocating peptide drug delivery system |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof |
| 06/20/2002 | WO2000065052A9 Bridge-1, a transcription factor |
| 06/20/2002 | WO2000061596A8 50 human secreted proteins |
| 06/20/2002 | WO2000052210A9 Methods for targeting rna molecules |
| 06/20/2002 | WO2000052185A9 Application of dna vectors for the treatment of viral infection |
| 06/20/2002 | WO2000052159A9 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 06/20/2002 | WO2000052158A9 Methods and reagents for inhibiting angiogenesis |
| 06/20/2002 | US20020077466 Protein for use in the diagnosis, prevention and treatment of nervous system and cell proliferation, kidney and urogenital disorders |
| 06/20/2002 | US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis |
| 06/20/2002 | US20020077313 Methods and compositions for the diagnosis and treatment of cancer |
| 06/20/2002 | US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders |
| 06/20/2002 | US20020077308 Methods of treating colitis using STAT-4 anti-sense oligonucleotides |
| 06/20/2002 | US20020077307 Methods for regulating gene expression |
| 06/20/2002 | US20020077305 Genetic immunization with cationic lipids |
| 06/20/2002 | US20020077291 Method of treatment of tumors using transforming growth factor-alpha |
| 06/20/2002 | US20020077273 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 06/20/2002 | US20020076811 Mammalian artificial chromosomes |
| 06/20/2002 | US20020076801 AAV DNA comprising helper virus sequences |
| 06/20/2002 | US20020076798 Liver-specific gene expression cassettes, and methods of use |
| 06/20/2002 | US20020076797 Purified and isolated piwi family genes and gene products and methods using same |
| 06/20/2002 | US20020076796 2786, a novel human aminopeptidase |
| 06/20/2002 | US20020076795 Novel TRF1 binding protein, methods of use thereof |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076784 Nucleotide sequences coding preferential polypeptide for use in the treatment of brain disorders, infections and viral diseases |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076756 Nucleotide sequences coding polypeptide for use in treatment of cancer and inflammation; for use as wound healing agent |
| 06/20/2002 | US20020076755 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/20/2002 | US20020076748 Nucleotide sequences coding animal cell growth regulator; for us ein the prevent defective cell proliferation; for use as a wound healing agent |
| 06/20/2002 | US20020076746 Macrophage inflammatory protein-4 (mip-4) polynucleotides |
| 06/20/2002 | US20020076737 Bladder nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 06/20/2002 | US20020076712 Human RNase H and compositions and uses thereof |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076702 Evaluating prostaglandin response to preferential modulators; obtain sample, incubate with modulator, compare profile with control, determine if human had prostaglandin response to moduator based on differences in control and sample profiles |
| 06/20/2002 | US20020076700 Nucleotide sequences coding secreted polypeptide; for use in treatment of cancer, autoimmune and skin disorders, allergies, infection, inflammation, arthritis, hematopoietic, atherosclerosis, restenosis and nervous system disorders |
| 06/20/2002 | US20020076441 A biodegradable gel matrix and a microparticle system wherein the microparticle is embedded in the biodegradable gel matrix, from which bioactive agent is released in a controlled manner |
| 06/20/2002 | US20020076419 Ligands added to adenovirus fiber |
| 06/20/2002 | US20020076418 Use of strains of parapoxvirus ovis against organ fibrosis |
| 06/20/2002 | US20020076414 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/20/2002 | US20020076413 Administering fragments, conformations, biological equivalent, or derivatives of antithrombin III; anticancer agents |
| 06/20/2002 | US20020076407 Method for selectively stimulating proliferation of t cells |
| 06/20/2002 | US20020076400 Adipose-derived stem cells and lattices |
| 06/20/2002 | US20020076399 Treatment of immune diseases |
| 06/20/2002 | US20020076398 Administering an agent that enhances Cyclic AMP response element binding protein (CREB) pathway function, training the animal to improve performance in the cognitive task; for people with central nervous system disorders |
| 06/20/2002 | US20020076395 Modified adipose tissue and related implants and methods |
| 06/20/2002 | US20020076394 Delivery system for gene therapy to the brain |
| 06/20/2002 | US20020076392 Non-antibody immunomodulatory molecules such as cytokines expressed as membrane-bound fusion proteins; vaccines; immunotherapy |
| 06/20/2002 | DE10154224A1 Composition for treating cardiac insufficiency, containing a construct that expresses basic helix-loop-helix transcription factors |
| 06/20/2002 | DE10061161A1 Neue humane Androgenrezeptor-Varianten New human androgen receptor variants |
| 06/20/2002 | CA2447900A1 Drug delivery compositions and medical devices containing block copolymer |
| 06/20/2002 | CA2436830A1 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | CA2431896A1 Compound |
| 06/20/2002 | CA2431646A1 Non-invasive method for detecting target rna |
| 06/20/2002 | CA2430297A1 Interferon-alpha induced gene |
| 06/20/2002 | CA2365494A1 Lawsonia intracellularis vaccine |
| 06/19/2002 | EP1215283A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1214945A2 Method and medicament for inhibiting the expression of a defined gene |
| 06/19/2002 | EP1214598A2 Screening for inhibitors of "paired helical filaments" |
| 06/19/2002 | EP1214454A1 Hepatitis c virus replication inhibitors |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214452A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214439A2 Smooth muscle cell promoter and uses thereof |
| 06/19/2002 | EP1214438A1 Improved methods and means for retroviral gene delivery |
| 06/19/2002 | EP1214423A1 Heparanase-2, a member of the heparanase protein family |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214416A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214408A1 Ribozymes used for restenosis prevention |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214403A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |